The current status of checkpoint inhibitors in metastatic bladder cancer

Fahmy, Omar; Khairul-Asri, Mohd Ghani; Stenzl, Arnulf; Gakis, Georgios

dc.contributor.author	Fahmy, Omar
dc.contributor.author	Stenzl, Arnulf
dc.contributor.author	Gakis, Georgios
dc.date.accessioned	2018-11-13T14:46:12Z
dc.date.available	2018-11-13T14:46:12Z
dc.date.issued	2016
dc.identifier.issn	1573-7276
dc.identifier.uri	http://hdl.handle.net/10900/84890
dc.language.iso	en	de_DE
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s10585-016-9807-9	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	The current status of checkpoint inhibitors in metastatic bladder cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20180405102126_01009
utue.publikation.seiten	629-635	de_DE
utue.personen.roh	Fahmy, Omar
utue.personen.roh	Khairul-Asri, Mohd Ghani
utue.personen.roh	Stenzl, Arnulf
utue.personen.roh	Gakis, Georgios
dcterms.isPartOf.ZSTitelID	Clinical & Experimental Metastasis	de_DE
dcterms.isPartOf.ZS-Issue	7	de_DE
dcterms.isPartOf.ZS-Volume	33	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE